Star Health Insurance will host in-person meetings with three institutional investors in Hong Kong on Thursday, August 06, 2026. The engagements are part of the company’s routine investor relations activities and aim to provide updates to key market participants. The meetings are scheduled across the day, involving Polymer Capital Management, Schroder Investment Management, and Zaaba Capital.

The disclosure was made in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Jayashree Sethuraman, Company Secretary & Compliance Officer, signed the intimation submitted to the BSE and NSE on July 31, 2026.

Meeting Schedule

The company has arranged separate time slots for each firm. All timings are in Hong Kong local time.

Disclosure Details

The company noted that the schedule is subject to changes due to exigencies on the part of the analysts or investors. A presentation link for the meeting was provided in the filing, accessible via the company’s cloud storage. The full disclosure is also available on the company’s website at www.starhealth.in .

What This Means for Investors

These meetings allow institutional investors to engage directly with management regarding business performance and strategy. While no specific financial results were announced in this filing, such engagements often precede or accompany quarterly earnings discussions. Investors should monitor subsequent filings for any material outcomes arising from these discussions.

Star Health and Allied Insurance Company Limited will conduct an in-person meeting with analysts and institutional investors on Wednesday, August 05, 2026, in Hong Kong. The event aims to engage with key global investment firms, providing them an opportunity to discuss the insurer’s strategic outlook and performance directly with management. This engagement reflects the company’s continued focus on maintaining transparent communication with its international investor base.

The disclosure was made in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company notified both the Bombay Stock Exchange and the National Stock Exchange of India Limited regarding the schedule. Jayashree Sethuraman, Company Secretary & Compliance Officer, signed the intimation.

Meeting Schedule

The company has allocated specific one-hour slots for each participating firm. All timings are listed in Hong Kong time.

The company noted that the schedule is subject to change due to exigencies on the part of the analysts or investors. A presentation deck related to the meeting is available for download via the company’s official website.

Regulatory Compliance

The intimation was filed under reference number SHAI/B & S/SE/62/2026-27. The disclosure ensures adherence to SEBI’s listing obligations regarding timely communication of material events to stock exchanges. The details are also hosted on the company’s website at www.starhealth.in for public access.